The company has a strong ability to develop new drugs and transform scientific and technological achievements. Azlocillin sodium for injection, Jin Aokang (omeprazole enteric-coated capsules), azithromycin and Jin Kang Puli (naproxen enteric-coated pellets capsules) were successively formed. Spectinomycin, amikacin sulfate and other brand products. Among them, Alixin, Jin Aokang, Amikacin Sulfate and other products are all "Zhejiang High-tech Products" and "Zhejiang Famous Brand Products"; Alexin is a "national key new product" and one of Zhejiang 100 fist products. The company's preparation sales company has passed the national drug GSP certification, and the marketing network radiates all major regions of the country; The sales of APIs have established long-term and stable cooperative relations with the United States, Italy, Germany, Switzerland, Brazil, India, Iran and other countries and regions.

The whole company has passed the national GMP certification, ISO900 1 certification and ISO 1400 1 certification, among which the oral solid preparation production line (including penicillin) has passed the European GMP certification, and the raw material spectinomycin production line has passed the US FDA and European GMP certification. The company has domestic leading production technology and equipment and first-class detection methods, and uses ERP management system to manage the whole production and operation process of the company to better meet customer needs. The company pays attention to employee training and continuing education, and promotes the growth of employees and the company through a relatively perfect modern human resource management system (HR).

The company will make full use of talents and scientific and technological advantages, carry forward the spirit of "honesty and trustworthiness, dedication and due diligence", pursue perfection, create first-class, and offer sincere love for human health.

Stock abbreviation: Kang Bain

Stock code: 600572

Stock Exchange: Shanghai Stock Exchange